|
|
|
Volumn 55, Issue 4, 1994, Pages 161-
|
|
Fluoxetine in dementia of the Alzheimer's type: Prominent adverse effects and failure to improve cognition [1]
a a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALCOHOL;
FLUOXETINE;
FLUVOXAMINE;
SEROTONIN UPTAKE INHIBITOR;
ABDOMINAL DISCOMFORT;
AGED;
AGITATION;
ALCOHOLISM;
ALZHEIMER DISEASE;
AMNESIA;
ANOREXIA;
BEHAVIOR DISORDER;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COGNITIVE DEFECT;
CONFUSION;
FEMALE;
HUMAN;
INSOMNIA;
LETTER;
MALE;
NAUSEA;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
VERTIGO;
WEIGHT REDUCTION;
AGED;
ALZHEIMER DISEASE;
COGNITION DISORDERS;
FEMALE;
FLUOXETINE;
HUMAN;
MALE;
PSYCHIATRIC STATUS RATING SCALES;
PSYCHOLOGICAL TESTS;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, NON-P.H.S.;
TREATMENT OUTCOME;
|
|
EID: 0028325410
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (21)
|
|
References (0)
|